ServiceNow, Inc. (NYSE:NOW) shares are trading lower after Keybanc analyst Jackson Ader downgraded the stock from Sector Weight to Underweight and announced a price target of $775. • ServiceNow stock is showing notable weakness. What’s behind NOW decline? Analyst View The analyst writes…
BofA Securities upgraded Bristol Myers Squibb & Co. (NYSE:BMY), citing near-term catalysts. “What we like about BMY is the valuation coupled with our forecast for a flattish 7-year outlook with risk-adjusted pipeline and favorable mix-related margin tailwinds. When we factor in multiple…
Applied Digital Corp (NASDAQ:APLD) shares are trending on Monday. Here’s a look at what you need to know. Applied Digital shares are retreating from recent levels. Why is APLD stock falling? What To Know: Applied Digital has shifted its primary focus…
IRobot Corp. (NASDAQ:IRBT) filed for Chapter 11 bankruptcy protection on Sunday, explicitly stating that under the Picea Robotics acquisition plan current shareholders will be wiped out. IRBT stock is crashing. See the chart and price action here. The equity value…
Wall Street traded little changed Monday after last Friday’s tech-led sell-off failed to trigger meaningful dip-buying interest. By midday trading in New York, major indexes hovered near flat levels as investors stayed cautious ahead of a dense macro calendar this…
Pfizer Inc. (NYSE:PFE) is scheduled to provide its full-year 2026 financial guidance on Tuesday, with Bank of America Securities expecting the company's growth profile to closely resemble conditions seen in 2025. According to BofA, Pfizer's outlook is likely to remain…
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.4% on Monday. The Dow traded down 0.27% to 48,328.47 while the NASDAQ fell 0.36% to 23,112.04. The S&P 500 also fell, dropping, 0.11% to 6,819.62. Check…
ABM Industries Incorporated (NYSE:ABM) will release earnings results for the fourth quarter before the opening bell on Wednesday, Dec. 17. Analysts expect the New York-based company to report quarterly earnings at $1.09 per share, up from 90 cents per share…
Gilead Sciences Inc. (NASDAQ:GILD) on Monday shared topline results from the Phase 3 ARTISTRY-2 trial. The trial evaluated the treatment responses of adults with HIV who are virologically suppressed, switching from Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide, B/F/TAF) to a fixed-dose combination of…
Immunome Inc. (NASDAQ:IMNM) stock rose Monday, with session volume surging to 8.25 million shares, well above the stock’s average daily volume of 1.50 million, according to Benzinga Pro data. Immunome on Monday shared topline results from the global pivotal Phase…